Deep Track Capital, LP
Filing Date
Global Rank
#680
/ 8,603
▲ 110
· as of Mar 2026
Top Industry
Biotechnology
86.4%
3Y Alpha vs SPY
+15.0%
Period ended 3 months ago
Filed May 15, 2026 · 55d
18 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+149.4%
SPY
+76.0%
Annualised alpha
+14.9%
Max drawdown
−50.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
62 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
6.4%
−0.8 pts
Top 5
26.9%
−5.4 pts
Top 10
44.4%
−10.0 pts
HHI
300
Diversified−95
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $4,846,263,139 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
23 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix, Inc | +11,615,868 | 19,686,282 | $166,742,808 | |
| CMPS | COMPASS Pathways plc | +4,827,173 | 12,161,496 | $67,253,072 | |
| MLTX | MoonLake Immunotherapeutics | +1,798,792 | 6,408,863 | $119,461,206 | |
| ALKS | Alkermes plc. | +1,590,323 | 3,590,323 | $126,953,821 | |
| BCAX | Bicara Therapeutics Inc. | +1,448,496 | 4,062,500 | $80,803,125 | |
| XFOR | X4 Pharmaceuticals, Inc | +1,325,874 | 6,339,535 | $26,182,279 | |
| VERA | Vera Therapeutics, Inc. | +1,284,932 | 4,106,067 | $165,187,075 | |
| CNTA | Centessa Pharmaceuticals plc | +1,158,041 | 3,158,041 | $125,437,388 | |
| JANX | Janux Therapeutics, Inc. | +1,097,701 | 1,187,290 | $16,503,331 | |
| CRMD | CorMedix Inc. | +1,000,000 | 6,274,076 | $42,600,976 | |
| IVA | Inventiva S.A. | +732,453 | 1,222,453 | $6,784,614 | |
| GRAL | GRAIL, Inc. | +700,000 | 1,722,797 | $89,034,148 | |
| TARS | Tarsus Pharmaceuticals, Inc. | +595,966 | 3,600,000 | $252,540,000 | |
| COGT | Cogent Biosciences, Inc. | +546,898 | 1,000,000 | $38,490,000 | |
| GH | Guardant Health, Inc. | +538,241 | 3,338,241 | $308,353,321 | |
| TERN | Terns Pharmaceuticals, Inc. | +304,829 | 1,073,877 | $56,614,795 | |
| PCVX | Vaxcyte, Inc. | +300,000 | 4,300,000 | $249,873,000 | |
| TNGX | Tango Therapeutics, Inc. | +295,438 | 2,750,000 | $57,530,000 | |
| IONS | Ionis Pharmaceuticals Inc | +250,000 | 1,950,000 | $146,425,500 | |
| GPCR | Structure Therapeutics Inc. | +168,066 | 4,279,848 | $206,288,673 | |
| ANIP | Ani Pharmaceuticals Inc | +122,316 | 600,000 | $46,140,000 | |
| SLNO | Soleno Therapeutics Inc | +78,710 | 1,078,710 | $36,115,210 | |
| BBIO | BridgeBio Pharma, Inc. | +31,303 | 841,445 | $62,485,705 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
14 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | −3,217,626 | 4,532,374 | $182,337,406 | |
| CYTK | Cytokinetics Inc | −1,962,678 | 1,374,320 | $90,581,431 | |
| BMRN | Biomarin Pharmaceutical Inc | −1,150,000 | 1,150,000 | $64,963,500 | |
| VRDN | Viridian Therapeutics, Inc.\DE | −1,130,889 | 1,393,944 | $27,265,544 | |
| GERN | Geron Corp | −790,993 | 31,720,278 | $47,263,214 | |
| MAZE | Maze Therapeutics, Inc. | −768,878 | 3,477,562 | $103,805,225 | |
| NRIX | Nurix Therapeutics, Inc. | −691,211 | 6,345,244 | $98,351,282 | |
| DYN | Dyne Therapeutics, Inc. | −650,000 | 2,000,000 | $36,260,000 | |
| CLDX | Celldex Therapeutics, Inc. | −616,759 | 1,283,979 | $40,727,813 | |
| HELP | Cybin Inc. | −541,118 | 1,313,137 | $6,303,057 | |
| MBX | MBX Biosciences, Inc. | −492,221 | 2,757,569 | $82,313,434 | |
| ORKA | Oruka Therapeutics, Inc. | −127,307 | 2,034,203 | $99,777,657 | |
| IMCR | Immunocore Holdings plc | −72,094 | 1,931,884 | $58,246,302 | |
| AXSM | Axsome Therapeutics, Inc. | −50,000 | 1,100,000 | $185,922,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
16 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALMS | Alumis Inc. | 6,772,595 | $149,200,267 | |
| NUVL | Nuvalent, Inc. | 1,376,324 | $141,004,393 | |
| GMAB | Genmab A/S | 3,663,250 | $98,284,997 | |
| DFTX | Definium Therapeutics, Inc. | 3,000,000 | $56,700,000 | |
| ATAI | AtaiBeckley Inc. | 12,000,000 | $42,480,000 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 2,491,539 | $36,451,215 | |
| ACRS | Aclaris Therapeutics, Inc. | 9,345,000 | $35,043,750 | |
| MANE | Veradermics, Inc | 500,000 | $31,575,000 | |
| SLDB | Solid Biosciences Inc. | 3,565,062 | $25,668,446 | |
| APGE | Apogee Therapeutics, Inc. | 285,000 | $23,988,450 | |
| KURA | Kura Oncology, Inc. | 2,643,542 | $21,491,996 | |
| IPSC | Century Therapeutics, Inc. | 9,487,745 | $21,442,303 | |
| BEAM | Beam Therapeutics Inc. | 820,765 | $19,558,829 | |
| PSNL | Personalis, Inc. | 3,000,000 | $19,110,000 | |
| PMN | ProMIS Neurosciences Inc. | 835,655 | $10,612,818 | |
| LRMR | Larimar Therapeutics, Inc. | 1,500,000 | $6,750,000 | |
| No positions match the current search. | ||||
62 positions ·
$4,846,263,139 total
· as of Mar 31, 2026
Showing 1–50
of 62 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GH |
Guardant Health, Inc.
Healthcare
|
Added | 3,338,241 | $308,353,321 | 6.36% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Held | 11,526,971 | $286,329,959 | 5.91% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 3,600,000 | $252,540,000 | 5.21% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 4,300,000 | $249,873,000 | 5.16% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 4,279,848 | $206,288,673 | 4.26% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 1,100,000 | $185,922,000 | 3.84% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 4,532,374 | $182,337,406 | 3.76% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Added | 19,686,282 | $166,742,808 | 3.44% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Added | 4,106,067 | $165,187,075 | 3.41% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 6,772,595 | $149,200,267 | 3.08% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 1,950,000 | $146,425,500 | 3.02% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
NEW | 1,376,324 | $141,004,393 | 2.91% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 3,590,323 | $126,953,821 | 2.62% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 3,158,041 | $125,437,388 | 2.59% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Added | 6,408,863 | $119,461,206 | 2.47% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Reduced | 3,477,562 | $103,805,225 | 2.14% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Reduced | 2,034,203 | $99,777,657 | 2.06% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 6,345,244 | $98,351,282 | 2.03% | |
| GMAB |
Genmab A/S
Healthcare
|
NEW | 3,663,250 | $98,284,997 | 2.03% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 1,374,320 | $90,581,431 | 1.87% | |
| GRAL |
GRAIL, Inc.
Healthcare
|
Added | 1,722,797 | $89,034,148 | 1.84% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Held | 3,352,804 | $82,680,146 | 1.71% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Reduced | 2,757,569 | $82,313,434 | 1.70% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 4,062,500 | $80,803,125 | 1.67% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Added | 12,161,496 | $67,253,072 | 1.39% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 1,150,000 | $64,963,500 | 1.34% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 841,445 | $62,485,705 | 1.29% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Reduced | 1,931,884 | $58,246,302 | 1.20% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 2,750,000 | $57,530,000 | 1.19% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 3,000,000 | $56,700,000 | 1.17% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,073,877 | $56,614,795 | 1.17% | |
| GERN |
Geron Corp
Healthcare
|
Reduced | 31,720,278 | $47,263,214 | 0.98% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Added | 600,000 | $46,140,000 | 0.95% | |
| CRMD |
CorMedix Inc.
Healthcare
|
Added | 6,274,076 | $42,600,976 | 0.88% | |
| ATAI |
AtaiBeckley Inc.
Healthcare
|
NEW | 12,000,000 | $42,480,000 | 0.88% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 1,283,979 | $40,727,813 | 0.84% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 1,000,000 | $38,490,000 | 0.79% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 2,491,539 | $36,451,215 | 0.75% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 2,000,000 | $36,260,000 | 0.75% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Added | 1,078,710 | $36,115,210 | 0.75% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
NEW | 9,345,000 | $35,043,750 | 0.72% | |
| MANE |
Veradermics, Inc
Healthcare
|
NEW | 500,000 | $31,575,000 | 0.65% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Held | 5,740,850 | $30,426,505 | 0.63% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Held | 4,377,572 | $29,811,265 | 0.62% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Reduced | 1,393,944 | $27,265,544 | 0.56% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Added | 6,339,535 | $26,182,279 | 0.54% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
NEW | 3,565,062 | $25,668,446 | 0.53% | |
| ENTA |
Enanta Pharmaceuticals Inc
Healthcare
|
Held | 1,956,867 | $24,715,230 | 0.51% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
NEW | 285,000 | $23,988,450 | 0.49% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
NEW | 2,643,542 | $21,491,996 | 0.44% |